account$5 billion in shares will be repurchased this year, Pfizer said. Pfizer yesterday completed its tender offer of King Pharmaceuticals Inc. The $3.6 billion offer in October received regulatory approval on Jan. 28 after repeated delays. The deal expands...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Plans to Cut Costs By Reducing Research, Shutting Plants
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account